Tech Company Financing Transactions
Supernus Pharmaceuticals Funding Round
Private investors invested in a $15 million capital raise for Supernus Pharmaceuticals. This venture round was announced on 2/2/2011.
Transaction Overview
Company Name
Announced On
2/2/2011
Transaction Type
Debt
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1550 East Gude Drive
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Not Recorded
Overview
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) is a specialty pharmaceuticals company that has a portfolio of proven and patented drug delivery technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jack Khattar
Chief Financial Officer
Gregory Patrick
Chief Medical Officer
Stefan Schwabe
VP - Marketing
Todd Horich
Browse more venture capital transactions:
Prev: 2/2/2011: Massive Health venture capital transaction
Next: 2/2/2011: GraphEffect venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs